Skip to main content

Halozyme Therapeutic (NQ: HALO )

38.20 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist

Other Filings

Form 424B3
Source: SEC/Edgar
September 18, 2005
Form 8-K
Source: SEC/Edgar
September 15, 2005
Form 8-K
Source: SEC/Edgar
September 13, 2005
Form 8-K
Source: SEC/Edgar
September 11, 2005
Form 8-K
Source: SEC/Edgar
September 01, 2005
Form 424B3
Source: SEC/Edgar
August 16, 2005
Form 8-K/A
Source: SEC/Edgar
August 15, 2005
Form 8-K
Source: SEC/Edgar
August 11, 2005
Form 10QSB
Source: SEC/Edgar
August 08, 2005
Form 8-K
Source: SEC/Edgar
August 07, 2005
Form 8-K
Source: SEC/Edgar
August 07, 2005
Form 424B3
Source: SEC/Edgar
July 26, 2005
Form S-2/A
Source: SEC/Edgar
July 18, 2005
Form 8-K
Source: SEC/Edgar
July 10, 2005
Form 8-K
Source: SEC/Edgar
July 05, 2005
Form S-2/A
Source: SEC/Edgar
June 20, 2005
Form 8-K
Source: SEC/Edgar
June 16, 2005
Form 8-K
Source: SEC/Edgar
June 16, 2005
Form S-3
Source: SEC/Edgar
June 09, 2005
Form 8-K
Source: SEC/Edgar
May 25, 2005
Form 8-K
Source: SEC/Edgar
May 24, 2005
Form 10QSB
Source: SEC/Edgar
May 19, 2005
Form NT 10-Q
Source: SEC/Edgar
May 15, 2005
Form 8-K
Source: SEC/Edgar
May 12, 2005
Form 10QSB
Source: SEC/Edgar
May 12, 2005
Form 144
Source: SEC/Edgar
April 21, 2005
Form 8-K
Source: SEC/Edgar
April 18, 2005
Form SC 13G
Source: SEC/Edgar
April 17, 2005
Form SC 13D
Source: SEC/Edgar
April 13, 2005
Form SC 13G
Source: SEC/Edgar
April 13, 2005
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.